AI assistant
MAYNE PHARMA GROUP LIMITED — Major Shareholding Notification 2012
Nov 7, 2012
65396_rns_2012-11-07_0daca261-54c8-4776-b738-594215077d4f.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Form 604
Corporations Law
Section 671B
Notice of change of interests of substantial holder
| То | Company Name/Scheme | MAYNE PHARMA GROUP LIMITED |
|---|---|---|
| ACN/ARSN | ||
| 1. | Details of substantial holder (1) | |
| Name | Watermark Funds Management | |
| ACN/ARSN (if applicable) | 105 845 970 | |
| There was a change in the interests of the substantial holder on |
07/11/12 | |
| ٥n | The previous notice was given to the company | 19/10/12 |
| The previous notice was dated | 16/10/12 |
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:
| Class of securities (4) | Previous notice | Present notice | ||
|---|---|---|---|---|
| ------------ | Person's voles | Voting power (5) . |
Person's voles | Voting power (5) |
| FPO | 19,594,390 | 8.67% | 19,594,390 | 5.61% |
| ويمثلون | ||||
| . |
*BASED ON ISSUED CAPITAL OF 349,577,657 SHARES
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting
securities of the company or scheme, since the substantial holder was last required to give
| Date of change |
Person whose relevant interest changed |
Nature of change (6) |
Consideration given in reletion to change (7) |
Class and number of securities affected |
Person's votes affected |
|---|---|---|---|---|---|
| 07/11/12 | Dilution of holdings | ||||
4. Present relevant interests
Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:
| See Schedule |
Person's votes |
|---|---|
SYD4_137740_1 (W97)
Schedule 1 - Change in substantial holdings in Mayne Pharma Group Limited
Watermark Funds Management/Australian Leaders Fund Limited
$\hat{\boldsymbol{\beta}}$
Details of relevant interests
| Holder of relevant interest | Nature of relevant interest | Class and number of securities | |||
|---|---|---|---|---|---|
| Watermark Funds Management | superannuation trusts, managed investment advisers of superannuation funds, pooled schemes and investment management discretionary investment managers or exercise vote and/or dispose of the securities as Power to (or to control) lagreements. |
19,594,390 Fully paid ordinary shares | |||
| Holder of relevant Interest | securities Registered Holder of |
Person entitled to be registed as holder |
Nature of relevant Interest |
Class and no. of securities |
Persons votes |
| Holder of relevant Interest | securities Registered Holder of |
Person entitled to be registed as holder |
Nature of relevant Interest |
Class and no. of securities |
Persons votes | |
|---|---|---|---|---|---|---|
| Australian Leaders Fund Limited | JBS Nominees Ltd | JBS Nominees Ltd | Investment Manager | 19,312,949 | 19,312,949 | |
| Watermark Funds Management | JBS Nominees Ltd | UBS Nominees Ltd | Investment Manager | 281,441 | 281,441 | |
$d_{\mu}^{\rm dip}$
$\frac{1}{2}$
Changes in association 5.
The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:
| Name and ACN/ARSN (if applicable) --------- |
. -------------------------------------- Nature of association |
|---|---|
| Not Applicable | |
| ______ ---- ------- |
|
| --------------------------------------- |
Addresses 6.
The addresses of persons named in this form are as follows:
| Name | The search and the con- Address |
|---|---|
| Australian Leaders Fund Limited | Level 11, 139 Macquarie Street, Sydney NSW 2000 . |
| Watermark Funds Management | Level 11, 139 Macquarie Street, Sydney NSW 2000 |
Signature
| print name | Justin Braitling | capacity |
Director |
|---|---|---|---|
| sign here | オフィティー | date | 08/11/12 |
| DIRECTIONS |
- If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related $(1)$ corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form. 합변
- (2) See the definition of 'associate' in section 9 of the Corporations Law.
- (3) See the definition of 'relevant interest' in sections 608 and 671B(7) of the Corporations Law.
- The voting shares of a company constitute one class unless divided into separate classes. $(4)$
- $(5)$ The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
- Include details of: $(6)$
- (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
- $(b)$ any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of 'relevant agreement' in section 9 of the Corporations Law.
- Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest $(7)$ was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit Is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
- (8) If the substantial holder is unable to determine the identity of the person (eg if the relevant interest arises because of an option) write unknown'.
- (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.